Clinical trial
Comparison Between Efficacy of Inhaled VS Intravenous Tranexamic Acid for Hemoptysis
NCT07845747 is registered in ClinicalTrials.gov with Dow University of Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison Between Efficacy of Inhaled VS Intravenous Tranexamic Acid for Hemoptysis
- Lead sponsor
- Dow University of Health Sciences
- Phase
- Phase 4
- Overall status
- Enrolling by invitation
- Start date
- September 15, 2026
- Completion date
- February 15, 2027
- Enrollment
- 154 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.